AMENDMENT TO THE LICENSE AND SUBLICENSE AGREEMENT BY AND BETWEEN CPEC LLC AND ARCA DISCOVERY INC.License and Sublicense Agreement • November 6th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
THIS INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of the 22nd day of February, 2006, by and among ARCA Discovery, Inc. a Delaware corporation (the “Company”), the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT BETWEEN ARCA DISCOVERY, INC. AND LABORATORY CORPORATION OF AMERICA HOLDINGS DATED FEBRUARY 1, 2007Development, Commercialization and Licensing Agreement • November 6th, 2009 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances
This Development, Commercialization and Licensing Agreement (this “Agreement”) is made and entered into as of February 1, 2007 (the “Effective Date”) between ARCA Discovery, Inc., a Delaware corporation (hereinafter “ARCA”), and Laboratory Corporation of America Holdings, a Delaware corporation (hereinafter “LabCorp”).
